Group 4I: Brain Metastasis; Real-world Data; Antibody-drug Conjugates

Name: Group 4I: Brain Metastasis; Real-world Data; Antibody-drug Conjugates
Start: 2023-12-15
End: 2023-12-15

Poster #PS11-07: High prevalence of HER2-Low and AR expression in breast cancer brain metastases provide novel therapeutic options.

Poster #PO5-16-10: The efficacy of novel antibody-drug-conjugates on brain metastases in metastatic breast cancer patients – a multicenter real-world analysis.